Table 2.
Site distribution and histopathological diagnosis of patients with lymphadenopathy
| Histological diagnosis | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||
| Site of biopsy | Number of cases | NHL | HL | Reactive | Necrotizing | Non-necrotizing | Kikuchi | Cat-scratch | Toxoplasmosis | Metastasis |
| Cervical | 71 (38.3%) | 17 (24%) | 19 (26.7%) | 20 (28.2%) | 7 (9.9%) | 1 (1.4%) | 1 (1.4%) | 1 (1.4%) | 1 (1.4%) | 4 (5.6%) |
| Axillary | 30 (16.2%) | 10 (33.3%) | 5 (16.7%) | 9 (30%) | 4 (13.4%) | - | - | 2 (6.6%) | - | - |
| Inguinal | 29 (15.6%) | 16 (55.1%) | 8 (27.5%) | 3 (10.4%) | - | - | - | 1 (3.5%) | - | 1 (3.5%) |
| Abdominal | 12 (6.4%) | 10 (83.4%) | - | - | - | - | - | - | - | 2 (16.6%) |
| Supraclavicular | 9 (4.8%) | 3 (33.4%) | 4 (44.4%) | 1 (11.1%) | 1 (11.1%) | - | - | - | - | - |
| Head | 23 (12.4%) | 13 (56.6%) | 1 (4.3%) | 7 (30.5%) | 1 (4.3%) | - | - | - | - | 1 (4.3%) |
| Mediasten | 11 (5.9%) | 7 (63.7%) | 1 (9%) | - | 2 (18.3%) | 1 (9%) | - | - | - | - |
| Total | 185 | 77 (41.6%) | 38 (20.6%) | 40 (21.6%) | 14 (7.6%) | 2 (1.1%) | 1 (0.5%) | 4 (2.2%) | 1 (0.5%) | 8 (4.3%) |
HL: Hodgkin lymphoma, NHL: Non-Hodgkin lymphoma.